A Houston law firm has filed suit against medical device maker Boston Scientific Corp. claiming the company sold defective vaginal mesh implants made from materials smuggled from China. This puts the health of thousands of women at risk. The defective vaginal mesh is used to treat urinary incontinence and other pelvic organ problems. The lawsuit […]Read More

Coloplast Corp., a manufacturer of ostomy and continence care products, has agreed to pay $3.6 million to resolve allegations that Coloplast paid unlawful kickbacks to several medical suppliers to induce them to conduct promotional campaigns designed to refer individual users to Coloplast products. Coloplast’s promotional campaigns allegedly included kickbacks in the form of funding for cash […]Read More

  Taylor Martino, PC Resolves a Medical Malpractice Against Surgeon Taylor Martino Rowan has resolved a medical malpractice case against a surgeon who performed a hemorrhoid surgery called a PPH Hemorrhoidectomy on a patient. PPH Hemorrhoidectomy is a typically a minimally invasive procedure to treat hemorrhoids and/or prolapse, During PPH, a stapler-like device is used to reposition the hemorrhoids and cut […]Read More

The law firm of Taylor Martino, PC recently resolved a medical malpractice case for a young Mississippi man for a confidential amount. The young man entered a hospital with an abscessed tooth and left the hospital with brain damage. The patient entered the hospital because he began experiencing breathing problems due to swelling. A medical […]Read More

We Are Reviewing Lawsuits For Injuries Caused By The Mirena IUD The product-liability lawyers at Taylor Martino Rowan are reviewing potential lawsuits for women who have experienced serious and debilitating problems while using the Mirena IUD. You may qualify to file a Mirena lawsuit if you suffered uterine perforation or other serious complications associated with […]Read More

Ed Rowan , Esq. shared his thoughts about smoke detectors to MOBILE, Ala. (WPMI)  The smoke detectors you likely have in your home right now may not alert you when it counts. Ninety percent of homes have ionization alarms, which has been proven to be much slower at detecting smoldering fires. Many, including the International […]Read More

OTTAWA – Health Canada initiated a safety review for the prescription diabetes drugs dapagliflozin (Forxiga) and canagliflozin (Invokana) and the risk of ketoacidosis, a serious condition that leads to high levels of blood acids called ketones. Dapagliflozin and canagliflozin are known as SGLT2 (sodium-glucose cotransporter-2) inhibitors and are approved in Canada for use in patients […]Read More

On May 15, 2015 the FDA announced it is investigating an association between Farxiga, Jardiance, and Invokana with diabetic ketoacidosis (DKA), ketoacidosis, or ketosis.  See: “FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood”. About a month later, Health Canada […]Read More

FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood [ 05-15-2015 ]The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines canagliflozin, dapagliflozin, and empagliflozin may lead to ketoacidosis, a serious condition where the body produces high levels of […]Read More

As of April 2015, dozens of recalls have been issued over the Medtronic Synchromed infusion pump system. Over 30 of these recalls have been deemed Class I recalls by the U.S. Food and Drug Administration (FDA). The FDA reached an agreement with Medtronic Inc. over flaws in its Synchromed drug infusion pump, a device that […]Read More